SCM
WVE icon

Silverarc Capital Management’s Wave Life Sciences WVE Stock Holding History

Silverarc Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100,000
Closed -$561K – 116
2021
Q1 		$561K Buy
+100,000
New +$961K 0.31% 69

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Silverarc Capital Management's WVE Position: Q2 2025 in Review

Silverarc Capital Management sold out of Wave Life Sciences (WVE) in Q2 2025, closing a stake of 1,050,374 shares — an estimated $8.49M sold.

Silverarc Capital Management first reported a position in WVE in Q1 2021 and held it in 8 quarters. The position peaked at $8.49M in Q1 2025. 176 funds tracked by Wall St. Rank hold WVE as of Q2 2025.

  • Silverarc Capital Management reported no remaining Wave Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 1,050,374 Wave Life Sciences shares in Q2 2025, an estimated $8.49M.
  • Silverarc Capital Management first reported a position in Wave Life Sciences in Q1 2021 and held it in 8 quarters.
  • Silverarc Capital Management's Wave Life Sciences position peaked at $8.49M in Q1 2025.
  • 176 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2025.

Based on Silverarc Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.